版本:
中国

BRIEF-Akari Therapeutics announces FDA fast track designation for Coversin

March 30 Akari Therapeutics Plc

* Akari Therapeutics announces FDA fast track designation for Coversin

* Akari Therapeutics Plc says is evaluating coversin in two Phase 2 clinical trials Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐